Search

Displaying results 6751 - 6760 of 10000 in total
  1. Drug

    OTI-030

    go.drugbank.com/drugs/DB05648
    Investigational

  2. Drug

    Iodofiltic acid I-123

    go.drugbank.com/drugs/DB05683
    Investigational

    Synonyms: I-123 BMIPP, Iodofiltic acid I 123
  3. Drug

    GW-559090

    go.drugbank.com/drugs/DB06508
    Experimental

  4. Drug

    Edaglitazone

    go.drugbank.com/drugs/DB06519
    Investigational

  5. Drug

    Tramiprosate

    go.drugbank.com/drugs/DB06527
    Investigational

  6. Drug

    Dextofisopam

    go.drugbank.com/drugs/DB06582
    Investigational

  7. Drug

    Omiganan

    go.drugbank.com/drugs/DB06610
    Investigational

    Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections.

  8. Drug

    Remetinostat

    go.drugbank.com/drugs/DB14869
    Investigational

    Remetinostat is under investigation in clinical trial NCT02213861 (Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma).

  9. Drug

    Penimepicycline

    go.drugbank.com/drugs/DB13264
    Experimental

    In the classification of the active ingredients included on this list, the classification document states that tetracycline class antibiotics are of medium importance, and are used in humans [L5620]. … Penimepicycline is a tetracycline-class antibiotic. It is mentioned on List A produced by the Government of Canada, which is a list of antimicrobial active pharmaceutical ingredients [L2791].

  10. Drug

    ChulaCov19 mRNA vaccine

    go.drugbank.com/drugs/DB16445
    Experimental

    The ChulaCov19 vaccine is mRNA-based and was developed in Thailand’s Chulalongkorn University in collaboration with the University of Pennsylvania in the US[L30673, L30678]. … The next phase of this study is for phase I and II clinical trials (NCT04566276) beginning in January 2021.